IssuerAnnouncementDetailsV2Portlet

Actions

Al-Razi Medical Co. announces its Annual Financial results for the period ending on 2023-12-31

9572
ALRAZI
14.29 %
1445/09/20     30/03/2024 16:24:15

Element ListCurrent YearPrevious Year%Change
Sales/Revenue 61,333,83152,390,48117.07
Gross Profit (Loss) 17,584,11016,099,8909.22
Operational Profit (Loss) 1,414,4652,592,346-45.44
Net profit (Loss) 685,9682,014,334-65.94
Total Comprehensive Income 674,0331,955,750-65.53
Total Share Holders Equity (After Deducting the Minority Equity) 22,369,27623,592,143-5.18
Profit (Loss) per Share 0.451.33
All figures are in (Actual) Saudi Arabia, Riyals


Element ListAmountPercentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value --
All figures are in (Actual) Saudi Arabia, Riyals


Element ListExplanation
The reason of the increase (decrease) in the sales/ revenues during the current year compared to the last year Revenues: The company achieved an increase in revenues of 8,943,350 million Saudi riyals, at a rate of (17.1%) over the previous year, 2022. This is due to the increase in sales through pharmacy branches opened in late 2022 and 2023.
The reason of the increase (decrease) in the net profit during the current year compared to the last year is Net profit: Net profit amounted to 685,968 Saudi riyals during the year 2023, a decrease of 66%. This decrease is due to the company investing in promotional offers to support sales of non-pharmaceutical products on the website and branches, and to the increase in selling and distribution expenses for new branches that are in the process of growth to achieve the sales target. .
Statement of the type of external auditor's report Unmodified opinion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) Attention: We would like to draw attention to Clarification No. (1), where the company announced in the Saudi Financial Market (Tadawul) that Al Razi Medical Company’s shares will be listed and begin trading in the (Nomu) market - the parallel market, starting from the 3rd of Dhul-Hijjah AH, corresponding to June 22nd. 2023 AD, with trading code 9572 and international code SA 15RoE4Li18
Reclassification of Comparison Items Some comparative figures have been reclassified to conform to the presentation of the financial statements for the current year.
Additional Information -

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.

Previous Announcements

View all announcements

Company Performance

ALRAZI
Add To Watchlist
In your Watchlist
Add To Watchlist
Key Parameters
Last Price 48.0
Net Change 6.0 (+14.29%)
Value Traded (Sar) 253,943.35
Volume Traded 5,883
See The Company Profile

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions
NO PORTLET SESSION YET